Click here to get full coverage on Stoke Therapeutics (STOK) director receives 30,782-share stock option grant - Stock Titan

Stoke Therapeutics (STOK) director receives 30,782-share stock option grant  Stock Titan

Stoke Therapeutics (STOK) director receives 30,782-share stock option grant - Stock Titan

Click here to get full coverage on Assessing Stoke Therapeutics (STOK) Valuation After Strong 1 Year Shareholder Returns - simplywall.st

Assessing Stoke Therapeutics (STOK) Valuation After Strong 1 Year Shareholder Returns  simplywall.st

Assessing Stoke Therapeutics (STOK) Valuation After Strong 1 Year Shareholder Returns - simplywall.st

Click here to get full coverage on (STOK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

(STOK) Price Dynamics and Execution-Aware Positioning  Stock Traders Daily

(STOK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Click here to get full coverage on My Favorite Store-Bought Coffee Is Better Than Any Drive-Thru Drink - Allrecipes

My Favorite Store-Bought Coffee Is Better Than Any Drive-Thru Drink  Allrecipes

My Favorite Store-Bought Coffee Is Better Than Any Drive-Thru Drink - Allrecipes

Click here to get full coverage on Stoke Therapeutics (STOK) director Kahn Clare submits initial Form 3 insider report - Stock Titan

Stoke Therapeutics (STOK) director Kahn Clare submits initial Form 3 insider report  Stock Titan

Stoke Therapeutics (STOK) director Kahn Clare submits initial Form 3 insider report - Stock Titan

Click here to get full coverage on STOK Aug 2026 40.000 put (STOK260821P00040000) stock historical prices and data - Yahoo Finance UK

STOK Aug 2026 40.000 put (STOK260821P00040000) stock historical prices and data  Yahoo Finance UK

STOK Aug 2026 40.000 put (STOK260821P00040000) stock historical prices and data - Yahoo Finance UK

Click here to get full coverage on Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - MSN

Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79  MSN

Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - MSN

Click here to get full coverage on We Ranked the Best Bottled Cold Brew Coffee—and Yes, Starbucks Cold Brew Made the List - Sporked

We Ranked the Best Bottled Cold Brew Coffee—and Yes, Starbucks Cold Brew Made the List  Sporked

We Ranked the Best Bottled Cold Brew Coffee—and Yes, Starbucks Cold Brew Made the List - Sporked

Click here to get full coverage on STOK Aug 2026 17.500 put (STOK260821P00017500) Interactive Stock Chart - Yahoo! Finance Canada

STOK Aug 2026 17.500 put (STOK260821P00017500) Interactive Stock Chart  Yahoo! Finance Canada

STOK Aug 2026 17.500 put (STOK260821P00017500) Interactive Stock Chart - Yahoo! Finance Canada

Click here to get full coverage on Clare Kahn joins Stoke Therapeutics (Nasdaq: STOK) board, receives option grant - Stock Titan

Clare Kahn joins Stoke Therapeutics (Nasdaq: STOK) board, receives option grant  Stock Titan

Clare Kahn joins Stoke Therapeutics (Nasdaq: STOK) board, receives option grant - Stock Titan

Click here to get full coverage on STOK Aug 2026 45.000 put (STOK260821P00045000) Interactive Stock Chart - Yahoo! Finance Canada

STOK Aug 2026 45.000 put (STOK260821P00045000) Interactive Stock Chart  Yahoo! Finance Canada

STOK Aug 2026 45.000 put (STOK260821P00045000) Interactive Stock Chart - Yahoo! Finance Canada

Click here to get full coverage on Stoke Therapeutics (STOK) Valuation After Strong 2025 Results And Progress In STK-002 And Zorevunersen - simplywall.st

Stoke Therapeutics (STOK) Valuation After Strong 2025 Results And Progress In STK-002 And Zorevunersen  simplywall.st

Stoke Therapeutics (STOK) Valuation After Strong 2025 Results And Progress In STK-002 And Zorevunersen - simplywall.st

Click here to get full coverage on Stoke Therapeutics (STOK) CMO sells 1,838 shares in planned open-market trade - Stock Titan

Stoke Therapeutics (STOK) CMO sells 1,838 shares in planned open-market trade  Stock Titan

Stoke Therapeutics (STOK) CMO sells 1,838 shares in planned open-market trade - Stock Titan

Click here to get full coverage on STOK Aug 2026 55.000 call (STOK260821C00055000) Interactive Stock Chart - Yahoo! Finance Canada

STOK Aug 2026 55.000 call (STOK260821C00055000) Interactive Stock Chart  Yahoo! Finance Canada

STOK Aug 2026 55.000 call (STOK260821C00055000) Interactive Stock Chart - Yahoo! Finance Canada

Click here to get full coverage on Insider sells shares under 10b5-1 — STOK (NASDAQ: STOK) discloses trades - Stock Titan

Insider sells shares under 10b5-1 — STOK (NASDAQ: STOK) discloses trades  Stock Titan

Insider sells shares under 10b5-1 — STOK (NASDAQ: STOK) discloses trades - Stock Titan

Click here to get full coverage on STOK Aug 2026 17.500 call (STOK260821C00017500) stock historical prices and data - Yahoo Finance Singapore

STOK Aug 2026 17.500 call (STOK260821C00017500) stock historical prices and data  Yahoo Finance Singapore

STOK Aug 2026 17.500 call (STOK260821C00017500) stock historical prices and data - Yahoo Finance Singapore

Click here to get full coverage on STOK Aug 2026 40.000 call (STOK260821C00040000) stock historical prices and data - Yahoo Finance Singapore

STOK Aug 2026 40.000 call (STOK260821C00040000) stock historical prices and data  Yahoo Finance Singapore

STOK Aug 2026 40.000 call (STOK260821C00040000) stock historical prices and data - Yahoo Finance Singapore

Click here to get full coverage on $STOK stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$STOK stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$STOK stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Michael Stok - Waukon Standard Newspaper

Michael Stok  Waukon Standard Newspaper

Michael Stok - Waukon Standard Newspaper

Click here to get full coverage on New Analyst Forecast: $STOK Given $60 Price Target | STOK Stock News - Quiver Quantitative

New Analyst Forecast: $STOK Given $60 Price Target | STOK Stock News  Quiver Quantitative

New Analyst Forecast: $STOK Given $60 Price Target | STOK Stock News - Quiver Quantitative

Click here to get full coverage on I Tried 10 Store-Bought Cold Brew Coffees and This Is the Only One Worth Buying - Allrecipes

I Tried 10 Store-Bought Cold Brew Coffees and This Is the Only One Worth Buying  Allrecipes

I Tried 10 Store-Bought Cold Brew Coffees and This Is the Only One Worth Buying - Allrecipes

Click here to get full coverage on Insider Sale: Chief Patient Officer of $STOK Sells 30 Shares - Quiver Quantitative

Insider Sale: Chief Patient Officer of $STOK Sells 30 Shares  Quiver Quantitative

Insider Sale: Chief Patient Officer of $STOK Sells 30 Shares - Quiver Quantitative

Click here to get full coverage on STOK Aug 2026 45.000 call (STOK260821C00045000) interactive stock chart - Yahoo Finance Singapore

STOK Aug 2026 45.000 call (STOK260821C00045000) interactive stock chart  Yahoo Finance Singapore

STOK Aug 2026 45.000 call (STOK260821C00045000) interactive stock chart - Yahoo Finance Singapore

Click here to get full coverage on (STOK) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

(STOK) as a Liquidity Pulse for Institutional Tactics  Stock Traders Daily

(STOK) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Click here to get full coverage on A Look At Stoke Therapeutics (STOK) Valuation After Recent Share Price Momentum - finance.yahoo.com

A Look At Stoke Therapeutics (STOK) Valuation After Recent Share Price Momentum  finance.yahoo.com

A Look At Stoke Therapeutics (STOK) Valuation After Recent Share Price Momentum - finance.yahoo.com

Click here to get full coverage on STOK Aug 2026 55.000 call (STOK260821C00055000) interactive stock chart - Yahoo Finance Singapore

STOK Aug 2026 55.000 call (STOK260821C00055000) interactive stock chart  Yahoo Finance Singapore

STOK Aug 2026 55.000 call (STOK260821C00055000) interactive stock chart - Yahoo Finance Singapore

Click here to get full coverage on STOK Aug 2026 55.000 call (STOK260821C00055000) stock historical prices and data - Yahoo Finance Singapore

STOK Aug 2026 55.000 call (STOK260821C00055000) stock historical prices and data  Yahoo Finance Singapore

STOK Aug 2026 55.000 call (STOK260821C00055000) stock historical prices and data - Yahoo Finance Singapore

Click here to get full coverage on Stoke Therapeutics (STOK) price target increased by 12.11% to 43.96 - MSN

Stoke Therapeutics (STOK) price target increased by 12.11% to 43.96  MSN

Stoke Therapeutics (STOK) price target increased by 12.11% to 43.96 - MSN

Click here to get full coverage on Allan Jonathan, Stoke Therapeutics general counsel, sells $313k in STOK stock - Investing.com

Allan Jonathan, Stoke Therapeutics general counsel, sells $313k in STOK stock  Investing.com

Allan Jonathan, Stoke Therapeutics general counsel, sells $313k in STOK stock - Investing.com

Click here to get full coverage on $STOK stock is down 18% today. Here's what we see in our data. | STOK Stock News - Quiver Quantitative

$STOK stock is down 18% today. Here's what we see in our data. | STOK Stock News  Quiver Quantitative

$STOK stock is down 18% today. Here's what we see in our data. | STOK Stock News - Quiver Quantitative

Click here to get full coverage on Stoke Therapeutics (STOK) Quarterly Losses Test Newly Profitable Trailing Earnings Narrative - simplywall.st

Stoke Therapeutics (STOK) Quarterly Losses Test Newly Profitable Trailing Earnings Narrative  simplywall.st

Stoke Therapeutics (STOK) Quarterly Losses Test Newly Profitable Trailing Earnings Narrative - simplywall.st

Click here to get full coverage on Vanguard reports zero Stoke Therapeutics holdings (STOK) - Stock Titan

Vanguard reports zero Stoke Therapeutics holdings (STOK)  Stock Titan

Vanguard reports zero Stoke Therapeutics holdings (STOK) - Stock Titan

Click here to get full coverage on STOK May 2026 45.000 put (STOK260515P00045000) interactive stock chart - Yahoo Finance UK

STOK May 2026 45.000 put (STOK260515P00045000) interactive stock chart  Yahoo Finance UK

STOK May 2026 45.000 put (STOK260515P00045000) interactive stock chart - Yahoo Finance UK

Click here to get full coverage on Why Stoke Therapeutics (STOK) Is Down 11.4% After NEJM Data on Dravet Syndrome Drug - And What's Next - simplywall.st

Why Stoke Therapeutics (STOK) Is Down 11.4% After NEJM Data on Dravet Syndrome Drug - And What's Next  simplywall.st

Why Stoke Therapeutics (STOK) Is Down 11.4% After NEJM Data on Dravet Syndrome Drug - And What's Next - simplywall.st

Click here to get full coverage on Stoke Therapeutics Inc (STOK) Q3 2025 Earnings Call Highlights: Strong Financial Position and ... - finance.yahoo.com

Stoke Therapeutics Inc (STOK) Q3 2025 Earnings Call Highlights: Strong Financial Position and ...  finance.yahoo.com

Stoke Therapeutics Inc (STOK) Q3 2025 Earnings Call Highlights: Strong Financial Position and ... - finance.yahoo.com

Click here to get full coverage on Stoke Therapeutics (NASDAQ: STOK) CFO sells 4,578 shares to cover RSU tax - Stock Titan

Stoke Therapeutics (NASDAQ: STOK) CFO sells 4,578 shares to cover RSU tax  Stock Titan

Stoke Therapeutics (NASDAQ: STOK) CFO sells 4,578 shares to cover RSU tax - Stock Titan

Click here to get full coverage on Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Beats Revenue Estimates - finance.yahoo.com

Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Beats Revenue Estimates  finance.yahoo.com

Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Beats Revenue Estimates - finance.yahoo.com

Click here to get full coverage on A Look at Stoke Therapeutics (STOK) Valuation After a 167% Year-to-Date Surge - finance.yahoo.com

A Look at Stoke Therapeutics (STOK) Valuation After a 167% Year-to-Date Surge  finance.yahoo.com

A Look at Stoke Therapeutics (STOK) Valuation After a 167% Year-to-Date Surge - finance.yahoo.com

Click here to get full coverage on Stoke Therapeutics (STOK): Exploring Valuation After a 2% Monthly Gain and 200% YTD Growth - finance.yahoo.com

Stoke Therapeutics (STOK): Exploring Valuation After a 2% Monthly Gain and 200% YTD Growth  finance.yahoo.com

Stoke Therapeutics (STOK): Exploring Valuation After a 2% Monthly Gain and 200% YTD Growth - finance.yahoo.com

Click here to get full coverage on Allan, Jonathan, Stoke Therapeutics general counsel, sells $285k in STOK - Investing.com

Allan, Jonathan, Stoke Therapeutics general counsel, sells $285k in STOK  Investing.com

Allan, Jonathan, Stoke Therapeutics general counsel, sells $285k in STOK - Investing.com

Click here to get full coverage on Stoke Therapeutics (STOK) CMO sells 14,311 shares in planned trades - Stock Titan

Stoke Therapeutics (STOK) CMO sells 14,311 shares in planned trades  Stock Titan

Stoke Therapeutics (STOK) CMO sells 14,311 shares in planned trades - Stock Titan

Click here to get full coverage on How Investors May Respond To Stoke Therapeutics (STOK) NEJM Data And 2027 FDA Filing Timeline - finance.yahoo.com

How Investors May Respond To Stoke Therapeutics (STOK) NEJM Data And 2027 FDA Filing Timeline  finance.yahoo.com

How Investors May Respond To Stoke Therapeutics (STOK) NEJM Data And 2027 FDA Filing Timeline - finance.yahoo.com

Click here to get full coverage on Leggett, Stoke Therapeutics CFO, sells $147k in STOK stock - Investing.com

Leggett, Stoke Therapeutics CFO, sells $147k in STOK stock  Investing.com

Leggett, Stoke Therapeutics CFO, sells $147k in STOK stock - Investing.com

Click here to get full coverage on Stoke Therapeutics (STOK) director adds 61,750 shares through RSU settlements - Stock Titan

Stoke Therapeutics (STOK) director adds 61,750 shares through RSU settlements  Stock Titan

Stoke Therapeutics (STOK) director adds 61,750 shares through RSU settlements - Stock Titan

Click here to get full coverage on Stoke Therapeutics (NASDAQ: STOK) counsel exercises 25,475 RSUs into shares - Stock Titan

Stoke Therapeutics (NASDAQ: STOK) counsel exercises 25,475 RSUs into shares  Stock Titan

Stoke Therapeutics (NASDAQ: STOK) counsel exercises 25,475 RSUs into shares - Stock Titan

Click here to get full coverage on Hoitt Jason, chief patient officer at Stoke, sells $119k in STOK stock - Investing.com

Hoitt Jason, chief patient officer at Stoke, sells $119k in STOK stock  Investing.com

Hoitt Jason, chief patient officer at Stoke, sells $119k in STOK stock - Investing.com

Click here to get full coverage on Anchor Line Partners Supports Stoke Therapeutics' Growth by Securing a 98,500 Square-Foot Lease in Waltham, MA - PR Newswire

Anchor Line Partners Supports Stoke Therapeutics' Growth by Securing a 98,500 Square-Foot Lease in Waltham, MA  PR Newswire

Anchor Line Partners Supports Stoke Therapeutics' Growth by Securing a 98,500 Square-Foot Lease in Waltham, MA - PR Newswire

Click here to get full coverage on Director at Stoke Therapeutics (STOK) sells 605 shares in plan trade - Stock Titan

Director at Stoke Therapeutics (STOK) sells 605 shares in plan trade  Stock Titan

Director at Stoke Therapeutics (STOK) sells 605 shares in plan trade - Stock Titan

Click here to get full coverage on Stoke Therapeutics (NASDAQ: STOK) counsel sells shares to cover tax withholding - Stock Titan

Stoke Therapeutics (NASDAQ: STOK) counsel sells shares to cover tax withholding  Stock Titan

Stoke Therapeutics (NASDAQ: STOK) counsel sells shares to cover tax withholding - Stock Titan

Click here to get full coverage on Insider Sale: Interim Executive Chair of $STOK Sells 4,355 Shares - Quiver Quantitative

Insider Sale: Interim Executive Chair of $STOK Sells 4,355 Shares  Quiver Quantitative

Insider Sale: Interim Executive Chair of $STOK Sells 4,355 Shares - Quiver Quantitative

Click here to get full coverage on STOK Apr 2026 55.000 call (STOK260417C00055000) Stock Price, News, Quote & History - Yahoo! Finance Canada

STOK Apr 2026 55.000 call (STOK260417C00055000) Stock Price, News, Quote & History  Yahoo! Finance Canada

STOK Apr 2026 55.000 call (STOK260417C00055000) Stock Price, News, Quote & History - Yahoo! Finance Canada

Click here to get full coverage on Stoke Therapeutics Inc (STOK) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic ... - finance.yahoo.com

Stoke Therapeutics Inc (STOK) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic ...  finance.yahoo.com

Stoke Therapeutics Inc (STOK) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic ... - finance.yahoo.com

Click here to get full coverage on $STOK stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

$STOK stock is up 12% today. Here's what we see in our data.  Quiver Quantitative

$STOK stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Stoke Therapeutics (NASDAQ:STOK) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Sees Unusually-High Trading Volume - Still a Buy?  MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat

Click here to get full coverage on Stoke Therapeutics (STOK) CFO exercises 14,750 RSUs, now holding 14,750 shares - Stock Titan

Stoke Therapeutics (STOK) CFO exercises 14,750 RSUs, now holding 14,750 shares  Stock Titan

Stoke Therapeutics (STOK) CFO exercises 14,750 RSUs, now holding 14,750 shares - Stock Titan

Click here to get full coverage on Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts  MarketBeat

Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on The Last Five Years Photos and Videos at Theater Stok 2025 36391 - BroadwayWorld

The Last Five Years Photos and Videos at Theater Stok 2025 36391  BroadwayWorld

The Last Five Years Photos and Videos at Theater Stok 2025 36391 - BroadwayWorld

Click here to get full coverage on STOK: Canaccord Genuity Raises Price Target to $60, Maintains Bu - GuruFocus

STOK: Canaccord Genuity Raises Price Target to $60, Maintains Bu  GuruFocus

STOK: Canaccord Genuity Raises Price Target to $60, Maintains Bu - GuruFocus

Click here to get full coverage on Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains? - finance.yahoo.com

Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains?  finance.yahoo.com

Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains? - finance.yahoo.com

Click here to get full coverage on Insider Selling: Stoke Therapeutics (NASDAQ:STOK) Director Sells 33,243 Shares of Stock - MarketBeat

Insider Selling: Stoke Therapeutics (NASDAQ:STOK) Director Sells 33,243 Shares of Stock  MarketBeat

Insider Selling: Stoke Therapeutics (NASDAQ:STOK) Director Sells 33,243 Shares of Stock - MarketBeat

Click here to get full coverage on Stoke Therapeutics (NASDAQ:STOK) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Stock Price Expected to Rise, Needham & Company LLC Analyst Says  MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat

Click here to get full coverage on Stoke Therapeutics (NASDAQ: STOK) officer sells 3,712 shares in tax-driven Form 4 - Stock Titan

Stoke Therapeutics (NASDAQ: STOK) officer sells 3,712 shares in tax-driven Form 4  Stock Titan

Stoke Therapeutics (NASDAQ: STOK) officer sells 3,712 shares in tax-driven Form 4 - Stock Titan

Click here to get full coverage on (STOK) Risk Channels and Responsive Allocation - Stock Traders Daily

(STOK) Risk Channels and Responsive Allocation  Stock Traders Daily

(STOK) Risk Channels and Responsive Allocation - Stock Traders Daily

Click here to get full coverage on Stoke Therapeutics (NASDAQ:STOK) shareholders are still up 246% over 3 years despite pulling back 4.8% in the past week - finance.yahoo.com

Stoke Therapeutics (NASDAQ:STOK) shareholders are still up 246% over 3 years despite pulling back 4.8% in the past week  finance.yahoo.com

Stoke Therapeutics (NASDAQ:STOK) shareholders are still up 246% over 3 years despite pulling back 4.8% in the past week - finance.yahoo.com

Click here to get full coverage on Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 7.2% - What's Next? - MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 7.2% - What's Next?  MarketBeat

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 7.2% - What's Next? - MarketBeat

Click here to get full coverage on Granahan Investment Management LLC Sells 278,514 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat

Granahan Investment Management LLC Sells 278,514 Shares of Stoke Therapeutics, Inc. $STOK  MarketBeat

Granahan Investment Management LLC Sells 278,514 Shares of Stoke Therapeutics, Inc. $STOK - MarketBeat

Click here to get full coverage on Stoke Therapeutics: FDA Delay Doesn't Change Zorevunersen's Opportunity (NASDAQ:STOK) - Seeking Alpha

Stoke Therapeutics: FDA Delay Doesn't Change Zorevunersen's Opportunity (NASDAQ:STOK)  Seeking Alpha

STOK

Price Chart

Key Statistics

Technicals

About STOK

Latest News

Stoke Therapeutics (STOK) director receives 30,782-share stock option grant - Stock Titan

Assessing Stoke Therapeutics (STOK) Valuation After Strong 1 Year Shareholder Returns - simplywall.st

(STOK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Advanced Charts

Top Gainers

Top Losers